Sarepta Therapeutics, Inc. Insider Transactions
Sarepta Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Boor Kathryn Jean
Director |
Sell | 1,636 @ $125.55 | $205,400 | 5,880 | 12/05/2024 | 12/06/2024 | |
| Sell | 5,985 @ $137.36 | $822,100 | 33,946 | 08/30/2024 | 09/03/2024 | ||
| Sell | 5,985 @ $137.36 | $822,100 | 33,946 | 08/30/2024 | 09/03/2024 | ||
|
Chambers Michael Andrew
Director |
Buy | 5,648 @ $134.66 | $760,560 | 284,034 | 08/16/2024 | 08/20/2024 | |
|
Chambers Michael Andrew
Director |
Buy | 5,648 @ $134.66 | $760,560 | 284,034 | 08/16/2024 | 08/20/2024 | |
|
Chambers Michael Andrew
Director |
Buy | 18,284 @ $134.06 | $2.45 M | 278,386 | 08/16/2024 | 08/20/2024 | |
|
Chambers Michael Andrew
Director |
Buy | 18,284 @ $134.06 | $2.45 M | 278,386 | 08/16/2024 | 08/20/2024 | |
|
Chambers Michael Andrew
Director |
Buy | 13,106 @ $133.07 | $1.74 M | 260,102 | 08/16/2024 | 08/20/2024 | |
|
Chambers Michael Andrew
Director |
Buy | 13,106 @ $133.07 | $1.74 M | 260,102 | 08/16/2024 | 08/20/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 7,644 @ $158.07 | $1.21 M | 48,442 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 7,644 @ $158.07 | $1.21 M | 48,442 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 2,200 @ $159.14 | $350,108 | 46,242 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 2,200 @ $159.14 | $350,108 | 46,242 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 975 @ $160.31 | $156,302 | 45,267 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 975 @ $160.31 | $156,302 | 45,267 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 4,168 @ $161.82 | $674,466 | 41,099 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 4,168 @ $161.82 | $674,466 | 41,099 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 17,581 @ $162.65 | $2.86 M | 23,518 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 17,581 @ $162.65 | $2.86 M | 23,518 | 06/25/2024 | 06/25/2024 | |
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 3,840 @ $163.53 | $627,955 | 19,678 | 06/25/2024 | 06/25/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sarepta Therapeutics, Inc. FAQ's
The list of insiders at Sarepta Therapeutics, Inc. includes Murray Dallan, Arif Bilal, Brown Ryan Edward, Chambers Michael Andrew, Estepan Ian Michael, Boor Kathryn Jean.
Insiders have sold a total of 118,669 Sarepta Therapeutics, Inc. shares in the last 12 months for a total of 18.79 M sold.
The following insiders have sold Sarepta Therapeutics, Inc. shares in the last 12 months: Murray Dallan ($508,900), Arif Bilal ($3.84 M), Brown Ryan Edward ($12.59 M), Estepan Ian Michael ($1.64 M), Boor Kathryn Jean ($205,400),
Insiders have purchased a total of 74,076 Sarepta Therapeutics, Inc. shares in the last 12 months for a total of 9.91 M.
The following insiders have purchased Sarepta Therapeutics, Inc. shares in the last 12 months: Chambers Michael Andrew ($9.91 M),